Authors
Latest:
Product Launch Strategies: Adapting Approaches in 2020 and BeyondWith new access levers emerging, positioning products will require a shift form the traditional launch playbook.
Latest:
Putting Predictive Market Research to the TestThere's a temptation for companies to view predictive markets as a silver bullet. Can crowds actually do a better job than "experts," or is that viewpoint more of a fad than a foundation for accurate future forecasting?
Latest:
How Not to Handle RebatesIn these cost cutting times, no drugmaker can afford to keep shoveling money down the Rebate Black Hole. Here's how to optimize your ROI and push back against the growing pressure of third-party rebates
Latest:
GSW Worldwide for MGI Pharma/Eisai's PONVTo educate anesthesiologists that post-operative nausea and vomiting (PONV) is "no fun for anyone," GSW Worldwide created WoozyWorld.com, a "non-amusement" that highlights the need for MGI Pharma's 72-hour antiemetic Aloxi.
Latest:
Decision Making at Digital SpeedIn an era in which companies can forfeit $1 million each day they delay a product launch-and being second can mean failure-pharma executives are under pressure to make risk and opportunity decisions in less time than ever.
Latest:
The importance of pre-call planningPre-call planning is a necessity if you're going to move your physicians and your productivity to another level.
Latest:
Biopharma Trends in 2024 and BeyondGenerative artificial intelligence, key new product launches, and the evolution of the go-to-market model are among key trends to watch in the year ahead.
Latest:
e-Pedigree to the Next DegreeElectronic pedigree is the future of supply chain security. Those still waiting and seeing might what to stop waiting and start tracking
Latest:
Salesforce RoundtableIndustry insiders explain how pharma companies are reorganizing their salesforces in the wake of industry-wide layoffs
Latest:
Emotion - The New Brand IntegratorDriven by the quest for innovation, the intensity of competition, and the pressure to create megabrands and megamergers, pharmaceutical executives are exploring an influential force still untapped by most marketing and communication departments-the power of emotion.
Latest:
The Holy Grail of Product DevelopmentDefining, evaluating, and utilizing the Target Product Profile.
Latest:
The Future of Media and Social Influence MarketingCommunications planning in 2009 and beyond will include online, offline, mobile, out-of-home, point-of-sale, gaming consoles, and more-even your car's navigation system will be tied to Google! Perhaps most importantly, communications planning will begin to include social influence marketing.
Latest:
Putting Predictive Market Research to the TestThere's a temptation for companies to view predictive markets as a silver bullet. Can crowds actually do a better job than "experts," or is that viewpoint more of a fad than a foundation for accurate future forecasting?
Latest:
Top 10 Detailing PitfallsCompetition for physicians' time has become so intense that some medical groups have severely restricted or banned reps altogether. Part of that strained relationship can be traced back to some of the sales techniques used by aggressive pharma salespeople. Physicians have become wary of being "sold" and often do not trust the information reps provide. Many doctors no longer feel that sales reps help provide better care for patients. Rather, physicians often come away feeling as though they just had an encounter with a used car dealer. To improve their relationships with medical professionals, pharma sales reps should avoid ten
Latest:
Wyeth V. Levine: An Attorneys' PerspectiveLawyers from Duane Morris LLP offer their take on the Supreme Court's groundshaking preemption decision
Latest:
Part 3: How to Enforce Post-Employment RestrictionsCourts are often hesitant to enforce such restrictions, so employers should take certain steps prior to and in the process of filing such a lawsuit.
Latest:
How Do You Solve a Problem Like Manufacturing?Outsourcing saves money-except when it doesn't. Here's how to decide what to do.
Latest:
Goodbye, Willy LomanThe days of pharma sales reps going office-to-office with samples and brochures are done. These days, they need to turn their attention to payers, pharmacists, and consumers
